Antidepressants increase β-arrestin2 ubiquitinylation and degradation by the proteasomal pathway in C6 rat glioma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 3, 2010, Pages 970-976

  Golan, Moran ^a   Schreiber, Gabriel ^a,b   Avissar, Sofia ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA ARRESTIN 2; CITALOPRAM; DESIPRAMINE; IMIPRAMINE; MESSENGER RNA; MOCLOBEMIDE; SHORT HAIRPIN RNA; UBIQUITIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG MECHANISM; GENETIC TRANSFECTION; GLIOMA CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARRESTINS; CELL LINE, TUMOR; GLIOMA; LEUPEPTINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; UBIQUITINS;

EID: 77249178904     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.160218     Document Type: Article

References (40)

1. Avissar S, Matuzany-Ruban A, Tzukert K, and Schreiber G (2004) β-Arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. Am J Psychiatry 161:2066-2072.
2. Banerjee SP, Kung LS, Riggi SJ, and Chanda SK (1977) Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268:455-456.
3. Blank M, Mandel M, Keisari Y, Meruelo D, and Lavie G (2003) Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin. Cancer Res 63:8241-8247.
4. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, and Barres BA (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120:421-433.
5. Czéh B, Simon M, Schmelting B, Hiemke C, and Fuchs E (2006) Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31:1616-1626.
6. Daniel WA (2003) Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27:65-73.
7. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, and Hen R (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62:479-493.
8. DeFea KA, Zalevsky J, Thoma MS, Déry O, Mullins RD, and Bunnett NW (2000) β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
9. DeWire SM, Ahn S, Lefkowitz RJ, and Shenoy SK (2007) β-Arrestins and cell signaling. Annu Rev Physiol 69:483-510.
10. Donati RJ and Rasenick MM (2005) Chronic antidepressant treatment prevents accumulation of Gsα in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30:1238-1245.
11. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, and Pandey GN (2001) Reduced activation and expression of ERK1/2 MAP kinase in the postmortem brain of depressed suicide subjects. J Neurochem 77:916-928.
12. Fishman PH and Finberg JP (1987) Effect of the tricyclic antidepressant desipramine on β-adrenergic receptors in cultured rat glioma C6 cells. J Neurochem 49:282-289.
13. Golan M, Schreiber G, and Avissar S (2009) Antidepressants, β-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions. Curr Pharm Des 15:1699-1708.
14. 2-andrenergic receptors in C6 glioma cells. Effects on catecholamine responsiveness. Receptor 5:185-195.
15. Hanley NR and Hensler JG (2002) Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine2A receptor. J Pharmacol Exp Ther 300:468-477.
16. Hindmarch I (2001) Expanding the horizons of depression: beyond the monoamine hypothesis. Hum Psychopharmacol 16:203-218.
17. Hisaoka K, Takebayashi M, Tsuchioka M, Maeda N, Nakata Y, and Yamawaki S (2007) Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J Pharmacol Exp Ther 321: 148-157.
18. Honegger UE, Disler B, and Wiesmann UN (1986) Chronic exposure of human cells in culture to the tricyclic antidepressant desipramine reduces the number of β-adrenoceptors. Biochem Pharmacol 35:1899-1902.
19. Kagaya A, Kugaya A, Hayashi T, Okamoto Y, Takebayashi M, Uchitomi Y, and Yamawaki S (1996) Effect of citalopram on the desensitization of serotonin-2A receptor-mediated calcium mobilization in rat glioma cells. Prog Neuropsychopharmacol Biol Psychiatry 20:157-166.
20. Lefkowitz RJ and Shenoy SK (2005) Transduction of receptor signals by β-arrestins. Science 308:512-517.
21. Leventopoulos M, Rüedi-Bettschen D, Knuesel I, Feldon J, Pryce CR, and Opacka-Juffry J (2007) Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res 1142:119-126.
22. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, and Wu GC (2009) Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. Eur Neuropsychopharmacol 19:796-805.
23. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, and Lefkowitz RJ (2001) Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci U S A 98:2449-2454.
24. Matuzany-Ruban A, Avissar S, and Schreiber G (2005) Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressants in mononuclear leukocytes of patients with depression. J Affect Disord 88:307-312.
25. McLennan GP, Kiss A, Miyatake M, Belcheva MM, Chambers KT, Pozek JJ, Mohabbat Y, Moyer RA, Bohn LM, and Coscia CJ (2008) Kappa opioids promote the proliferation of astrocytes via Gβγ and β-arrestin 2-dependent MAPK-mediated pathways. J Neurochem 107:1753-1765.
26. Mercier G, Lennon AM, Renouf B, Dessouroux A, Ramaugé M, Courtin F, and Pierre M (2004) MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 24:207-216.
27. Miyatake M, Rubinstein TJ, McLennan GP, Belcheva MM, and Coscia CJ (2009) Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by μ opioids: integration of G protein and β-arrestin 2-dependent pathways. J Neurochem 110:662-674.
28. Nishida H and Okabe S (2007) Direct astrocytic contacts regulate local maturation of dendritic spines. J Neurosci 27:331-340.
29. Ongür D, Drevets WC, and Price JL (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95:13290-13295.
30. Peroutka SJ and Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88-90.
31. Prenner L, Sieben A, Zeller K, Weiser D, and Häberlein H (2007) Reduction of high-affinity β2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy. Biochemistry 46:5106-5113.
32. Racagni G and Popoli M (2008) Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 10:385-400.
33. Rajkowska G and Miguel-Hidalgo JJ (2007) Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6:219-233.
34. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, and Blasig IE (2008) Serum markers support disease-specific glial pathology in major depression. J Affect Disord 111:271-280.
35. Scott MG, Le Rouzic E, Périanin A, Pierotti V, Enslen H, Benichou S, Marullo S, and Benmerah A (2002) Differential nucleocytoplasmic shuttling of β-arrestins. Characterization of a leucine-rich nuclear export signal in β-arrestin2. J Biol Chem 277:37693-37701.
36. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, and Luttrell LM (2003) The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278:6258-6267.
37. Tsujimura A, Matsuki M, Takao K, Yamanishi K, Miyakawa T, and Hashimoto-Gotoh T (2008) Mice lacking the kf-1 gene exhibit increased anxiety-but not despair-like behavior. Front Behav Neurosci 2:4.
38. Wang P, Wu Y, Ge X, Ma L, and Pei G (2003) Subcellular localization of β-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 278:11648-11653.
39. Wolfe BB, Harden TK, Sporn JR, and Molinoff PB (1978) Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther 207:446-457.
40. Yamada M, Yamada M, Yamazaki S, Takahashi K, Nishioka G, Kudo K, Ozawa H, Yamada S, Kiuchi Y, Kamijima K, Higuchi T, and Momose K (2000) Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain. Biochem Biophys Res Commun 278:150-157.